{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:59:07Z","timestamp":1785362347520,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhlto.2026.100594","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:47:27Z","timestamp":1778770047000},"page":"100594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation"],"prefix":"10.1016","volume":"13","author":[{"given":"Fahmi A.","family":"AL-Kaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"AlRifaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Songor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-5844","authenticated-orcid":false,"given":"Mohammed","family":"Alreshidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jhlto.2026.100594_bib1","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.jhlto.2026.100594_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jchf.2021.05.009","article-title":"Advanced heart failure epidemiology and outcomes","volume":"9","author":"Dunlay","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"ement_C","key":"10.1016\/j.jhlto.2026.100594_bib3","doi-asserted-by":"crossref","first-page":"C283","DOI":"10.1093\/eurheartjsupp\/suad028","article-title":"Advanced heart failure: from definitions to therapeutic options","volume":"25","author":"Garascia","year":"2023","journal-title":"Eur Heart J Suppl"},{"issue":"5","key":"10.1016\/j.jhlto.2026.100594_bib4","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jtcvs.2013.10.070","article-title":"Universal definition of perioperative bleeding in adult cardiac surgery","volume":"147","author":"Dyke","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"22","key":"10.1016\/j.jhlto.2026.100594_bib5","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMra067742","article-title":"Prevention and treatment of major blood loss","volume":"356","author":"Mannucci","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jhlto.2026.100594_bib6","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1537-2995.2007.01432.x","article-title":"Variability and predictability of large-volume red blood cell transfusion in cardiac surgery: a multicenter study","volume":"47","author":"Karkouti","year":"2007","journal-title":"Transfusion (Paris)"},{"issue":"10","key":"10.1016\/j.jhlto.2026.100594_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1537-2995.2004.04144.x","article-title":"The independent association of massive blood loss with mortality in cardiac surgery","volume":"44","author":"Karkouti","year":"2004","journal-title":"Transfusion (Paris)"},{"issue":"5","key":"10.1016\/j.jhlto.2026.100594_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ejcts.2007.02.001","article-title":"Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes\u2606","volume":"31","author":"Choong","year":"2007","journal-title":"Eur J Cardio-Thorac Surg"},{"issue":"3","key":"10.1016\/j.jhlto.2026.100594_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ahj.2011.11.016","article-title":"Impact of major bleeding and blood transfusions after cardiac surgery: Analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial","volume":"163","author":"Stone","year":"2012","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100594_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/stcs.2000.20511","article-title":"Management of bleeding and coagulopathy after heart surgery","volume":"12","author":"Milas","year":"2000","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.jhlto.2026.100594_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/jcm11030773","article-title":"Cardiac surgery in advanced heart failure","volume":"11","author":"Hullin","year":"2022","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.jhlto.2026.100594_bib12","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jhlto.2026.100594_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/ALN.0000000000000463","article-title":"Practice Guidelines for Perioperative Blood Management","volume":"122","year":"2015","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.jhlto.2026.100594_bib14","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jth.12948","article-title":"Antithrombotic therapy for left ventricular assist devices in adults: a systematic review","volume":"13","author":"Baumann Kreuziger","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100594_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","article-title":"An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial","volume":"33","author":"Najjar","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100594_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MAT.0000000000000497","article-title":"Medical management of pump-related thrombosis in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis","volume":"63","author":"Dang","year":"2017","journal-title":"ASAIO J"},{"issue":"21","key":"10.1016\/j.jhlto.2026.100594_bib17","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1161\/CIRCULATIONAHA.117.028303","article-title":"Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months","volume":"135","author":"Uriel","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jhlto.2026.100594_bib18","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.jhlto.2026.100594_bib19","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A fully magnetically levitated left ventricular assist device \u2014 final report","volume":"380","author":"Mehra","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jhlto.2026.100594_bib20","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.jhlto.2026.100594_bib21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIa in hemostasis","volume":"108","author":"Mackman","year":"2009","journal-title":"Anesth Analg"},{"issue":"S 1","key":"10.1016\/j.jhlto.2026.100594_bib22","doi-asserted-by":"crossref","first-page":"077","DOI":"10.1055\/s-2006-939557","article-title":"Mechanism of action of factor VIIa in the treatment of coagulopathies","volume":"32","author":"Hedner","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.jhlto.2026.100594_bib23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1213\/ANE.0000000000004355","article-title":"Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients","volume":"129","author":"Raphael","year":"2019","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100594_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.jvca.2017.06.026","article-title":"2017 EACTS\/EACTA Guidelines on patient blood management for adult cardiac surgery","volume":"32","author":"Boer","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100594_bib25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4103\/aca.ACA_108_18","article-title":"J. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage","volume":"22","author":"Feih","year":"2019","journal-title":"Ann Card Anaesth"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100594_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsha.2016.03.001","article-title":"Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery","volume":"28","author":"Habib","year":"2016","journal-title":"J Saudi Heart Assoc"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100594_bib27","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1053\/j.jvca.2021.03.021","article-title":"Efficacy, safety, and strategies for recombinant-activated factor VII in cardiac surgical bleeding: a narrative review","volume":"36","author":"Kidd","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100594_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1749-8090-2-32","article-title":"Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant","volume":"2","author":"Gandhi","year":"2007","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100594_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1749-8090-2-47","article-title":"Recombinant activated factor VII (Novo7\u00ae) in patients with ventricular assist devices: case report and review of the current literature","volume":"2","author":"Heise","year":"2007","journal-title":"J Cardiothorac Surg"},{"issue":"6","key":"10.1016\/j.jhlto.2026.100594_bib30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/jocs.12555","article-title":"Efficacy and safety of recombinant factor VII as rescue for severe perioperative bleeding in HeartMate II recipients","volume":"30","author":"Karimi","year":"2015","journal-title":"J Card Surg"},{"issue":"8","key":"10.1016\/j.jhlto.2026.100594_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.healun.2009.04.028","article-title":"High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII","volume":"28","author":"Bruckner","year":"2009","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.jhlto.2026.100594_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10047-020-01228-2","article-title":"Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices","volume":"24","author":"Gyoten","year":"2021","journal-title":"J Artif Organ"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100594_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.athoracsur.2019.01.016","article-title":"Reversal and resumption of antithrombotic therapy in LVAD-associated intracranial hemorrhage","volume":"108","author":"Cho","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100594_bib34","doi-asserted-by":"crossref","first-page":"S372","DOI":"10.1016\/j.healun.2019.01.947","article-title":"Safety and efficacy of recombinant factor VII in HeartMate 3 recipients","volume":"38","author":"Ayers","year":"2019","journal-title":"J Heart Lung Transplant"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:19:49Z","timestamp":1785359989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133426001151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"alternative-id":["S2950133426001151"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100594","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100594"}}